Search for a command to run...
Both Promoter and Institution shareholding in Ipca Laboratories has decreased year-over-year and quarter-over-quarter, contrasting with sector averages where there are no changes.
The Public shareholding remains stable, but this lack of retail enthusiasm amid declining smart money suggests potential concerns about the stock's future performance.
In comparison to sector movers, Ipca's negative trends highlight it as underperforming relative to peers like SANOFICONR and SUDARSHAN, which are seeing institutional investments.
| Category | Trend | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|
1Promoter13 | 46.28% | 46.28% | 46.29% | 46.29% | 46.29% | 44.72% | 44.72% | 44.72% | |
2Institution13 | 31.46% | 30.85% | 30.72% | 31.28% | 29.1% | 29.54% | 28.77% | 30.27% | |
3Public2 | 0.34% | 0.37% | 0.34% | 0.33% | 0.34% | 0.31% | 0.34% | 0.34% |